Cyclin D2 (CCND2), which is often lost in breast cancer due to promoter hypermethylation [19-20], was significantly downregulated in LFS stromal cells, compared to WT (6.6 fold; p<0.012), suggesting a marked dysregulation of the cell cycle in these stromal cells. Here, CCND2 is linked to breast carcinoma.